BETHESDA, Md., Dec. 19, 2011 /PRNewswire-Asia/ -- Chindex International, Inc. (NASDAQ: CHDX), an American health care company providing health care services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced that the Company will present at the 30th Annual J.P. Morgan Healthcare Conference, to be held January 9-12, 2012 at the Westin St. Francis Hotel in San Francisco. Management is currently scheduled to present at 9:30 am PT on Wednesday, January 11, 2012 and to meet with institutional investors throughout the day. A webcast of the presentation will be available via the Company's IR website at http://ir.chindex.com. For further details, please contact your J.P. Morgan institutional sales representative. About Chindex International, Inc. Chindex is an American health care company providing health care services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics. United Family Healthcare currently operates in Beijing, Shanghai and Guangzhou. The Company also provides medical capital equipment and products through Chindex Medical Ltd., a joint venture company with manufacturing and distribution businesses serving both domestic China and export markets. With thirty years of experience, the Company's strategy is to continue its growth as a leading integrated health care provider in the Greater China region. Further company information may be found at the Company's website at http://www.chindex.com. Contact: ICR, Inc. Ashley De Simone(646) 277-1227 SOURCE Chindex International, Inc.
Chindex (CHDX) spiked to a five-year high of $19.71 on Tuesday after the announcement that TPG and Shanghai Fosun Pharmaceutical would acquire the drug manufacturer. The deal is worth $369 million, and the consortium will pay $19.50 per share in cash for Chindex. Founder and Chief Executive Officer Roberta Lipson will stay on as CEO after the deal. The deal should give TPG and Fosun a foothold in China's private healthcare sector, which has been growing quickly as the Chinese government invests in it to alleviate pressure on public hospitals and to drive down prices through more competition in the market.
Shares of Chindex International (Nasdaq:CHDX) have taken a tremendous swing upward. The stock is trading at $10.09 as of 10:51 a.m. ET, 20.1% above Monday's closing price of $8.40. Volume is at 51,498, 0.9 times the daily average of 56,300.